STOCK TITAN

Maravai LifeSciences Holdings, Inc. (MRVI) Debt by Year

MRVI

Maravai LifeSciences Holdings, Inc. carried $286.3M in long-term debt against $216.9M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 1.4% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Maravai LifeSciences Holdings, Inc. has filed alongside them.

FY2025 annual
Long-Term Debt $286.3M
Cash & Equivalents $216.9M
YoY -1.4%
5Y CAGR -11.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MRVI Debt & Cash by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Long-Term Debt$286.3M-1.4%$290.5M-44.0%$518.7M-0.6%$522.0M-0.5%$524.6M-0.8%$528.6MN/A
Cash & Equivalents$216.9M-32.7%$322.4M-43.9%$575.0M-9.0%$632.1M+14.7%$551.3M+133.4%$236.2M+856.2%$24.7M

MRVI Debt & Cash by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Long-Term Debt$146.0M-49.4%$235.6M-18.6%$286.3M-1.4%$287.4M-44.3%$288.4M-44.2%$289.5M-44.1%$290.5M-44.0%$516.3M-0.6%$517.1M-0.6%$517.9M-0.6%$518.7M-0.6%$519.5M-0.6%
Cash & Equivalents$70.1M-74.0%$165.9M-41.8%$216.9M-32.7%$243.6M-57.9%$269.9M-52.9%$285.1M-49.3%$322.4M-43.9%$578.2M-0.2%$573.2M-1.2%$561.7M-10.6%$575.0M-9.0%$579.6M-6.1%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Maravai LifeSciences Holdings, Inc. financials

Frequently Asked Questions

What was Maravai LifeSciences Holdings, Inc.'s long-term debt in fiscal year 2025?

Maravai LifeSciences Holdings, Inc. carried $286.3M in long-term debt against $216.9M in cash and equivalents at the end of fiscal year 2025.

How fast is Maravai LifeSciences Holdings, Inc.'s long-term debt growing?

Maravai LifeSciences Holdings, Inc. (MRVI) long-term debt fell by 1.4% year over year, from $290.5M to $286.3M in fiscal year 2025.

What was Maravai LifeSciences Holdings, Inc.'s long-term debt in the most recent quarter?

Maravai LifeSciences Holdings, Inc. (MRVI) reported $146.0M in long-term debt in Q2 2026. This represents a decrease of 49.4% from the same quarter a year earlier.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Maravai LifeSciences Holdings, Inc. (MRVI) reported on that line in every period on record.